top of page
gradientForSurfBreak.png

Item List

Newswires
xCures partners with RenovoRx to assist patients in accessing RenovoRx’s TIGeR-PaC study

xCures, Inc. is proud to announce their partnership with RenovoRx, a clinical-stage biopharmaceutical company that focuses on fighting cancer through localized treatment of difficult-to-treat tumors, such as pancreatic adenocarcinoma. Through this collaboration, xCures will help eligible pancreatic cancer patients access a Phase III clinical study entitled, Targeted Intra-arterial Gemcitabine vs. Continuation of IV Gemcitabine plus Nab-Paclitaxel following Induction with sequential IV Gemcitabine plus Nab-Paclitaxel and Radiotherapy for Unresectable Locally Advanced Pancreatic Cancer (TIGeR-PaC).

Recent Posts

Wavemaker 360 News

Carlsmed.png

Episode 108: Jay Goss, General Partner at Wavemaker Three-Sixty Health ...

MedTech Money

Portfolio Company

Carlsmed.png

Strados Labs forms collaboration with Boehringer Ingelheim for its Idiopathic Pu ...

Cision PR Newsire

Portfolio Company

Carlsmed.png

Caduceus Capital Partners, Wavemaker Three-Sixty Health Co-Lead Series A Investm ...

Businesswire

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page